Dünya genelinde her bir pazarın taleplerine, lojistik gereksinimlerine ve düzenlemelerine uygun şekilde çalışıyoruz.
Daha fazla bilgi almak için lütfen ilgilendiğiniz ülkeye tıklayın.
Cancer, undoubtedly, is one of the most challenging diseases faced today. Its far-reaching impact affects people of all ages, genders and backgrounds making it a global health crisis of immense proportions. Clinical trials play a key role in the search for effective treatments and oncology remains the leading therapy area across the globe as researchers seek a cure.
Among the many drugs being tested and developed, one stands out prominently – Keytruda®. Keytruda®, also known as pembrolizumab, is emerging as one of the breakthrough drugs in cancer treatments. It has been used successfully as a treatment across a variety of cancers and is expected to become the world’s top-selling drug by 2023. Keytruda® has been shown to delay the worsening and improve survival from the following cancers1:
The success of Keytruda® has been remarkable, offering new hope to patients with various stages of cancer. The drug’s success has led to its approval for use in an expanding range of indications, ensuring that more patients can benefit from its potential.
Increased demand for Keytruda® can lead to increased costs on the open market. Oximio can surmount this by offering the best market price and shortest supply route. In addition to securing the best price for Keytruda, the company can obtain the appropriate expiry and batch requirements.
With an extensive global network of depots and warehouses, we can also offer flexible and cost-effective logistic solutions. Worldwide shipping can be arranged on a DAP bases and blind shipping is also possible if required.
If you are seeking a quotation for Keytruda for clinical trials, please contact us today. We will be delighted to discuss your requirements and obtain the best available market price.
How can we help you?
Would you like to learn more about our...
First, please complete the form and submit your question.
Hello! How can I assist you today?